Tag: MS treatment

Increased Risk of Severe COVID With Anti-B-Cell MS Drugs?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Concerns are being raised over an increased risk of severe COVID-19...

Masitinib Impresses in ‘Nonactive’ Progressive MS

The investigational drug, masitinib (AB Science), which has a completely new mechanism of action for multiple sclerosis (MS), has shown a positive result in slowing...

Lessons for Patients With MS and COVID-19

Two important lessons about managing patients with multiple sclerosis (MS) and COVID-19 have emerged from a hospital clinic in Madrid that managed COVID-infected patients with...

NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Measuring serum levels of neurofilament light chain (NfL) is an effective way of detecting disease activity and the need to optimize treatment in patients with...

Depression Linked to Neuro Dysfunction, Brain Lesions in MS

Depression is associated with decreased neurologic function and new brain lesions in patients with multiple sclerosis (MS), new research suggests. In an observational study of...

Reassuring’ Study Examines COVID-19 Risk in MS

What your doctor is reading on Medscape.com: MAY 08, 2020 — Multiplesclerosis (MS) may not be one of the more serious comorbidities when it...

‘Reassuring’ Study Examines COVID-19 Risk in MS

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s  Coronavirus Resource Center. Multiple sclerosis (MS) may not be one of the more serious...

Five-Year Siponimod Data Support Early MS Treatment

Among patients with secondary progressive multiple sclerosis (MS) who received siponimod or placebo during a double-blind trial and entered an open-label extension, those who received...

Joint ACTRIMS/ECTRIMS Conference Still a Go Despite Pandemic

What your doctor is reading on Medscape.com: APRIL 22, 2020 — The show will go on. In some shape or form, organizers of...